The European Society of Human Genetics has expressed concern over the way some commercial companies are introducing direct-to-consumer genetic tests onto the market, outside the scope of traditional healthcare systems1,2.
The society’s concerns are listed in a draft policy paper on which stakeholders can submit feedback until 16 May...
Please login to read the full article.
